These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Steroid 5-alpha-reductase type 2 (SRD5A2) gene V89L polymorphism and hypospadias risk: A meta-analysis. Zhang K, Li Y, Mao Y, Ma M. J Pediatr Urol; 2017 Dec; 13(6):630.e1-630.e9. PubMed ID: 28713005 [Abstract] [Full Text] [Related]
13. The Molecular Basis of 5α-Reductase Type 2 Deficiency. Batista RL, Mendonca BB. Sex Dev; 2022 Dec; 16(2-3):171-183. PubMed ID: 35793650 [Abstract] [Full Text] [Related]
14. Correlation of androgen receptor and SRD5A2 gene mutations with pediatric hypospadias in 46, XY DSD children. Fu XH, Zhang WQ, Qu XS. Genet Mol Res; 2016 Mar 31; 15(1):15018232. PubMed ID: 27051040 [Abstract] [Full Text] [Related]
15. Steroid 5alpha-reductase 1 polymorphisms and testosterone/dihydrotestosterone ratio in male patients with hypospadias. Tria A, Hiort O, Sinnecker GH. Horm Res; 2004 Mar 31; 61(4):180-3. PubMed ID: 14739525 [Abstract] [Full Text] [Related]
16. The valine allele of the V89L polymorphism in the 5-alpha-reductase gene confers a reduced risk for hypospadias. Thai HT, Kalbasi M, Lagerstedt K, Frisén L, Kockum I, Nordenskjöld A. J Clin Endocrinol Metab; 2005 Dec 31; 90(12):6695-8. PubMed ID: 16174723 [Abstract] [Full Text] [Related]
17. Molecular genetic analysis of AKR1C2-4 and HSD17B6 genes in subjects 46,XY with hypospadias. Mares L, Vilchis F, Chávez B, Ramos L. J Pediatr Urol; 2020 Oct 31; 16(5):689.e1-689.e12. PubMed ID: 32732174 [Abstract] [Full Text] [Related]